Level B· Emerging clinical evidence with positive signalsClinical TrialPubMed

Adult stem cells for cardiovascular diseases: the adipose tissue potential.

Roche R., Hoareau L., Mounet F., Festy F.

Clinical Trial on Type 2 Diabetes, Cardiovascular Disease, published in Expert Opin Biol Ther (2007) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
Expert Opin Biol Ther (2007)
Country
England
Reported sample size
—
Source database
PubMed
PMID
17555365
DOI
10.1517/14712598.7.6.791

Abstract (original English)

Cardiovascular diseases, as well as cardiac ischemia and lower limb vascularization, are associated with obesity and Type II diabetes, and pose a major public health problem. Recent advances in understanding stem cell biology have prompted the initiation of clinical trials of cardiac and vascular cell therapy. Autologous adult stem cells are generally taken from bone marrow or circulating blood. Although significant and encouraging results have been obtained in human studies where these cells have been employed, obtaining sufficient numbers of these cells is a major constraint. Recent studies have identified adipose tissue as a new source of stem cells; some of which may be suitable for the restoration of cardiovascular function. As lipoaspiration provides relatively simple access to this stem cell pool, and with the very large numbers of cells present in adipose tissue, its future potential as a stem cell reservoir for cardiovascular cell therapy is promising.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
Adipose TissueAdult Stem CellsAnimalsBone Marrow CellsBone Marrow TransplantationCardiovascular DiseasesCell DifferentiationCell LineageCell ProliferationEndothelial Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research